XSpray Pharma, акция обыкновенная (SE0009973563, XSPRAY, 0GHZ, 6XP)

XSpray Pharma AB is a product development company with several product candidates in clinical development. It develops, sells and licenses generic versions of marketed cancer drugs, protein kinase inhibitors. The company primarily develops protein kinase inhibitors (PKI) for targeted cancer treatment.

• Активы
• Капитал
• Общий долг / Капитал
• Чистая прибыль
• EBITDA
• Чистый долг / EBITDA
• Выручка
• Рентабельность по EBITDA (%)